Showing results (1381-1390 of 2,857) with videos related to
Sort By:
Pageof 286
Pathology Oncology Research : POR|December 9, 2022
Immunological role and prognostic value of SPARCL1 in pan-cancer analysisKangwei He, Changjiu Li, Hui Yuan, et al.Pathology Oncology Research : POR|December 12, 2022
Pulmonary Combined Large Cell Neuroendocrine CarcinomaMeihui Li, Lan Yang, Hongyang LuPathology Oncology Research : POR|May 9, 2022
HLA Class I Downregulation in Progressing Metastases of Melanoma Patients Treated With IpilimumabAndrea Ladányi, Barbara Hegyi, Tímea Balatoni, et al.Pathology Oncology Research : POR|March 31, 2020
Comparison of Epstein-Barr Virus Serological Tools for the Screening and Risk Assessment of Nasopharyngeal Carcinoma: a Large Population-based StudyJunying Guo, Zhaolei Cui, Yuhong Zheng, et al.Pathology Oncology Research : POR|July 16, 2021
Efficacy of Clarithromycin Depends on the Bacterial Density in Clarithromycin-Heteroresistant Helicobacter pylori Infections: An In Situ Detected Susceptibility and Quantitative Morphometry-Based Retrospective StudyJewel Ju Ea Kim, Ildikó Kocsmár, György Miklós Buzás, et al.Pathology Oncology Research : POR|July 14, 2021
Case Report: Mucinous Adenocarcinoma Arising From Congenital Ejaculatory Duct CystHua Shen, Kai Liao, Weili Wu, et al.Pathology Oncology Research : POR|July 14, 2021
Silencing Osteopontin Expression Inhibits Proliferation, Invasion and Induce Altered Protein Expression in Melanoma CellsTímea Kiss, Krisztina Jámbor, Viktória Koroknai, et al.Pathology Oncology Research : POR|July 14, 2021
Overexpression of PELP1 in Lung Adenocarcinoma Promoted E2 Induced Proliferation, Migration and Invasion of the Tumor Cells and Predicted a Worse Outcome of the PatientsDongmei Zhang, Jiali Dai, Yu Pan, et al.Pathology Oncology Research : POR|July 14, 2021
Identification of Prognostic Related Genes of Tumor Microenvironment Derived From Esophageal Cancer PatientsWei Yuan, Jiaqin Yan, Hongtao Liu, et al.Pathology Oncology Research : POR|July 14, 2021
Association of Lung Adenocarcinoma Subtypes According to the IASLC/ATS/ERS Classification and Programmed Cell Death Ligand 1 (PD-L1) Expression in Tumor CellsGraciela Cruz-Rico, Alejandro Avilés-Salas, Xitlally Popa-Navarro, et al.Pageof 286